|Free Dividend Report|
|Stock Splits Calendar|
|ACRS Historical Stock Prices|
|Preferred Stock Newsletter|
|ACRS Options Chain|
|Stock Message Boards|
Aclaris Therapeutics (ACRS) has the following price history information. Looking back at ACRS historical stock prices for the last five trading days, on November 22, 2023, ACRS opened at $0.90, traded as high as $0.91 and as low as $0.77, and closed at $0.81. Trading volume was a total of 5.08M shares. On November 24, 2023, ACRS opened at $0.82, traded as high as $0.88 and as low as $0.79, and closed at $0.84. Trading volume was a total of 2.52M shares. On November 27, 2023, ACRS opened at $0.83, traded as high as $0.89 and as low as $0.77, and closed at $0.87. Trading volume was a total of 3.68M shares. On November 28, 2023, ACRS opened at $0.87, traded as high as $0.90 and as low as $0.81, and closed at $0.89. Trading volume was a total of 1.92M shares. On November 29, 2023, ACRS opened at $0.93, traded as high as $0.98 and as low as $0.86, and closed at $0.88. Trading volume was a total of 5.07M shares.
ACRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aclaris Therapeutics shares, starting with a $10,000 purchase of ACRS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-26.71%|
|ACRS Historical Price Range|
|About Aclaris Therapeutics|
|Aclaris Therapeutics is a biopharmaceutical company that develops drug candidates for immuno-inflammatory diseases. Co.'s pipeline of drug candidates includes Zunsemetinib, which is for the indication of rheumatoid arthritis (moderate to severe), psoriatic arthritis (moderate to severe), and hidradenitis suppurativa (moderate to severe); ATI-1777, which is for the indication of atopic dermatitis (moderate to severe); ATI-2138, which is for the indication of T cell-mediated autoimmune diseases; Gut-Biased Program, which is for the indication of inflammatory bowel disease; and ATI-2231, which is for the indication of metastatic breast cancer and pancreatic cancer.|
|ACRS Historical Closing Prices|
|Healthcare Historical Prices|
|ACRS is categorized under the Healthcare sector; below are some other companies in the same sector:
ACRX Historical Stock Prices
Also explore: ACRS shares outstanding history
ACRS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights ReservedNothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.